Tenaya Therapeutics (TNYA) USD0.0001

Sell:$1.16Buy:$1.17$0.04 (2.94%)

NASDAQ:2.15%
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.16
Buy:$1.17
Change:$0.04 (2.94%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.16
Buy:$1.17
Change:$0.04 (2.94%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 November 2025
Faraz AliCEO
Sell
Tax related
3,126$1.33$4,157.58299,666
17 November 2025
Whittemore (Whit) TingleyOther Level A
Sell
Tax related
2,877$1.33$3,826.41169,926
17 November 2025
Tomohiro (Hiro) HigaSenior Vice President
Sell
Tax related
1,367$1.33$1,818.1193,971
18 August 2025
Faraz AliCEO
Sell
Tax related
5,720$1.25$7,167.16311,605
18 August 2025
Faraz AliCEO
Sell
Tax related
3,893$1.25$4,877.93307,712
18 August 2025
Faraz AliCEO
Sell
Tax related
4,920$1.25$6,164.76302,792
18 August 2025
Whittemore (Whit) TingleyOther Level A
Sell
Tax related
1,608$1.25$2,014.82176,248
18 August 2025
Whittemore (Whit) TingleyOther Level A
Sell
Tax related
1,608$1.25$2,014.82174,640
18 August 2025
Whittemore (Whit) TingleyOther Level A
Sell
Tax related
1,837$1.25$2,301.76172,803
18 August 2025
Tomohiro (Hiro) HigaSenior Vice President
Sell
Tax related
523$1.25$655.3297,777

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 March 2025
COLUMN GROUP III GP LPVenture Capital
Buy
Regular purchase transaction
35,714,284$0.70$24,999,998.8049,313,559
18 August 2025
Faraz AliCEO
Sell
Tax related
5,720$1.25$7,167.16311,605
18 August 2025
Faraz AliCEO
Sell
Tax related
4,920$1.25$6,164.76302,792
18 August 2025
Faraz AliCEO
Sell
Tax related
3,893$1.25$4,877.93307,712
17 November 2025
Faraz AliCEO
Sell
Tax related
3,126$1.33$4,157.58299,666

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.